Le Lézard
Classified in: Health, Science and technology

Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development


BEIJING, Aug. 7, 2022 /CNW/ -- The 2022 Taihu Bay Future Healthcare Conference held Thursday in Wuxi City in east China's Jiangsu Province witnessed the launch of Wuxi Intellectual Property Protection Center with 52 biomedical projects contracted, involving a total of more than 30 billion yuan investment.

Biomedical industry is an important part of Wuxi's modern industrial system construction during the 14th Five-Year Plan(2021-2025) period. Its scale topped 140 billion yuan in 2021, a year-on-year increase of 24 percent, making Wuxi among the top 20 prefecture-level cities listed in China Biomedical Industry Barometer in 2021.

Besides the property protection center, six biomedical industrial parks were licensed and three biomedical public platforms were inaugurated at the conference, which are expected to inject impetus to the development of Wuxi's biomedical industry.

The city will strengthen and expand its industrial chain to build a 200-billion-yuan modern biomedical industrial cluster, said Du Xiaogang, Secretary of the Wuxi Municipal Party Committee of CPC.

The biomedical industry started early in Wuxi. With good foundation, it has developed a relatively comp industry chain covering chemical raw medicine production, preparation production, and pharmaceutical service outsourcing, and gathered 1,278 biomedical companies such as AstraZeneca and WuXi Biologics AppTech, showing strong clustering effect. 

Aiming at building a world-class biomedical industry highland with distinctive characteristics, Wuxi not only issued a special policy tailored for the development of biomedical industrial parks, but also established a special fund for modern biomedical industry to reward breakthrough in the forward-looking technologies and innovation research. In 2021, Wuxi funded more than 32 million yuan for the science and technology development of 43 biomedical projects. 

Multiple fund agreements were signed at the conference, including a biomedical fund of 5 billion yuan jointly established by Guolian Group, AstraZeneca, and China International Capital Corporation Limited.

Original link: https://en.imsilkroad.com/p/329376.html

SOURCE Xinhua Silk Road


These press releases may also interest you

at 08:40
On 22nd September 2022, G2, the world's largest and most trusted software marketplace, released its highly-anticipated reports for the Fall quarter of this year. Kualitee, a complete test and defect management platform, is honoured to be recognized...

at 07:45
The Canadian Red Cross is encouraging people who are impacted by Hurricane Fiona to register with Red Cross by calling 1-800-863-6582, between the hours of 8 a.m. and 8 p.m. ADT or online at www.redcross.ca/hurricanefiona. Registration with the Red...

24 sep 2022
With explosions of color mimicking Mother Nature herself, the sustainably fashioned creations of Fashion Institute of Design and Merchandising (FIDM) student Andres Guerra were brought to life by multimedia influencer Lexy Silverstein, who wore the...

24 sep 2022
The Canadian Red Cross has launched the Hurricane Fiona in Canada Appeal to support people across eastern Canada who have been impacted by this devastating hurricane. Money raised will enable the Red Cross to carry out relief, recovery, resiliency...

24 sep 2022
Three social change organizations are partnering on a new and unique approach to philanthropy by funding and advancing digital equity advocacy in California...

24 sep 2022
Be Kind has chosen Benicia, California as its latest community. Being selected as a Be Kind community is to raise awareness for the importance of kindness within the local community. The weekly initiatives aim to influence the public to have a...



News published on 7 august 2022 at 23:35 and distributed by: